With the participation of existing investors – Karma Ventures, Inovo Venture Partners and DreamIT Ventures, as well as two new co-lead investors, EBRD and heal capital, Infermedica raised $10.25M Series A.
Infermedica is a team of over 100 people – medical doctors, software engineers, and data scientists – who are passionate about the potential of artificial intelligence in preliminary medical diagnosis.
Their solutions have been used over 6 million times in 17 language versions.
This additional funding will enable Infermedica to continue developing the technology and expand commercial operations, especially in the US and Germany.
